Indian Journal of Physical Medicine and Rehabilitation

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  31 (2020)
Volume  30 (2019)
Volume  29 (2018)
Volume  28 (2017)
Volume  27 (2016)
Volume  26 (2015)
Volume  25 (2014)
Volume  24 (2013)
Volume  23 (2012)
Related articles

VOLUME 28 , ISSUE 2 ( April-June, 2017 ) > List of Articles

RESEARCH ARTICLE

Effect of Infliximab Therapy in Functional Improvement in Patients with Ankylosing Spondylitis

Ambar Konar, Debayan Ghorai, Aniketa Banerjee

Citation Information : Konar A, Ghorai D, Banerjee A. Effect of Infliximab Therapy in Functional Improvement in Patients with Ankylosing Spondylitis. Indian J Phy Med Rehab 2017; 28 (2):59-63.

DOI: 10.5005/jp-journals-10066-0003

Published Online: 00-06-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

PDF Share
  1. Ankylosing spondylitis. In: Firestein GS, editor. Kelley's textbook of rheumatology. 9th ed. Philadelphia (PA): Saunders; 2012.
  2. A five-year cumulative analysis of labor-status and lost working days in patients with ankylosing spondylitis (AS). Arthritis Rheum 1998 Sep;41(9):S222.
  3. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997 Jul;36(7):766-771.
  4. ; Skosey, JL. Ankylosing spondylitis and related spondyloarthropathies. In Samter M, editor. Immunological diseases. Boston (MA): Little, Brown; 1989. p. 1509-1538.
  5. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis 2006 Sep;65(9):1147-1153.
  6. Sulfasalazine in the treatment of spondyloarthropathy. Arthritis Rheum 1995 May;38(5):618-627.
  7. Methotrexate in severe ankylosing spondylitis: a randomised placebo controlled, double-blind observer study. Rheumatology 2001;40(Suppl 1):43.
  8. Efficacy of methotrexate in ankylosing spondylitis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2004 Aug;31(8):1568-1574.
  9. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized placebo-controlled trial (ASSERT). Arthritis Rheum 2005 Feb;52(2):582-591.
  10. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006 Jul;54(7):2136-2146.
  11. Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab. Arthritis Res Ther 2005 Feb;7(3):R439-R444.
  12. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988 Feb;15(2):302-307.
  13. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 2000 Jun;43(6):1346-1352.
  14. Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis. J Rheumatol 2001 Jul;28(7):1605-1614.
  15. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 2008 Jan;1:CD002822.
  16. Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial. Arthritis Rheum 2006 Aug;55(4):569-574.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.